Single Use Bioprocessing Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033

The single use bioprocessing market size has grown rapidly in recent years. It will grow from $22.34 billion in 2023 to $26.71 billion in 2024 at a compound annual growth rate (CAGR) of 19.6%. The growth in the historic period can be attributed to biopharmaceutical production, biotechnology and cell culture processes, reduction of cross-contamination risks, regulatory compliance in bioprocessing, demand for cost-effective solutions..

The single use bioprocessing market size is expected to see exponential growth in the next few years. It will grow to $55.84 billion in 2028 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to expansion of personalized medicine, gene and cell therapy production, continuous bioprocessing adoption, biomanufacturing for rare diseases, expansion of biosafety levels, emerging markets and global biomanufacturing hubs.. Major trends in the forecast period include automated and robotic single-use systems, single-use sensors and analytics, closed-system aseptic filling and packaging, modular and scalable bioprocessing facilities, on-demand and decentralized biomanufacturing, virus filtration and purification solutions..

Market Overview -
Single-use bioprocessing refers to bioprocessing equipment designed to be used only once and then discarded. These are generally made of plastic components that are sterilized using gamma radiation. It can help save cleaning time, water, and energy consumption. Single-use bioprocessing is used throughout the bioproduction workflow with the minimum risk of cross-contamination.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=7700&type=smp

Surging Demand For Biopharmaceuticals Fuels Growth Of Single-Use Bioprocessing Market
The surge in demand for biopharmaceuticals is expected to propel the growth of the single-use bioprocessing market going forward. Biopharmaceuticals are medicines made from living cells or organisms. Single-use bioprocessing systems are commonly used in biopharmaceutical manufacturing for increasing productivity, saving costs, and safe disposal of waste. For instance, in June 2022, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical production in Europe accounted for $351 billion (€300,000 million) in 2021, with an increase of approximately 5% from $335.2 billion (€286,697 million) in 2020. Therefore, the increasing demand for biopharmaceuticals is driving the growth of the single-use bioprocessing market.

Competitive Landscape -
Major companies operating in the single use bioprocessing market include GE Healthcare Technologies Ltd., Eppendorf AG, Corning Incorporated, Thermo Fisher Scientific Inc., Sartorius AG, JM BioConnect BV, Merck KGaA, Pall Corporation, Kuhner AG, PBS Biotech Inc., Entegris Inc., DistriCell Inc., ABEC Inc., Able Corporation and Biott Corporation, Solida Biotech GmbH, OmniBRx Biotechnologies Pvt. Ltd., Satake Chemical Equipment Mfg. Co. Ltd., Stobbe Pharma GmbH, Celltainer Biotech BV, Cellexus BV, Danaher Corporation, Boehringer Ingelheim International GmbH, General Electric Company, Rentschler Biopharma SE, Repligen Corporation, Sollesis Medical Plc, Charter Medical Inc., Secant Group LLC, Lonza Group Ltd., Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Pfizer Inc., Catalent Inc., Patheon Inc., Bio-Rad Laboratories Inc., Avantor Performance Materials India Limited, MilliporeSigma, Saint-Gobain Performance Plastics Corp., Meissner Filtration Products Inc.

Sustaining Market Dominance Through Technological Advancements In Single-Use Bioprocessing
Technological advancements are a key trend gaining popularity in the single-use bioprocessing market. Major companies operating in the single-use bioprocessing market are integrating compueter technologies to sustain their position. For instance, in April 2023, Cytiva, a U.S.-based company, introduced X-platform bioreactors designed to enhance efficiency in single-use upstream bioprocessing. These bioreactors, initially available in sizes ranging from 50 to 200 liters, come equipped with the Figurate automation solution software. They are engineered to improve process efficiency by increasing production capacity, enhancing ergonomics, and streamlining supply chain operations.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report

Key Segments -

The single use bioprocessing market covered in this report is segmented -

1) By Product: Single-Use Media Bags And Containers, Single-Use Assemblies, Single-Use Bioreactors, Disposable Mixers, Other Products.
2) By Workflow: Upstream, Fermentation, Downstream
3) By Application: Filtration, Storage, Cell Culture, Mixing, Purification
4) By End User: Biopharmaceutical And Pharmaceutical companies, Contract Research Organizations And Contract Manufacturing Organizations (CROs and CMOs), Academic and Research institutes

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.